retatrutide dosing trial Dosing: Early Clinical Insights on How It Might Work Retatrutide—A Game Changer in Obesity
Description
Benefits of Retatrutide Therapy Unprecedented Weight Loss Early phase trials (NEJM 2023) showed average weight loss of ~24% at 48 weeks, which rivals bariatric surgery outcomes
The wrong one, or no program at all, makes everything worse
Improved Insulin Sensitivity Boosts Ovulation For those with insulin resistance or PCOS , GLP-1 therapy helps regulate insulin levels, which can normalize ovulation and improve conception chances
This paper is part of a Supplement that was financially supported by the ERA
